Healthcare News Newborn Screening Market | Page 2

REPORT DESCRIPTION
Newborn Screening Market – Overview
The global newborn screening market size was valued at US$ 561.5 million in 2018, and is expected to
witness a CAGR of 12.4% over the forecast period (2018 – 2026).
Newborn screening describes various tests that are performed during first few hours or days of an infant’s
life. These tests have the potential for preventing severe health problems, including death. Newborn
screening has evolved from a simple urine or blood screening test to a more comprehensive and complex
screening system capable of detecting over 50 different conditions. Newborn screening tests measure a
number of markers in infant’s blood that can be either decreased or increased if an infant has certain
diseases. Currently, conditions such as cystic fibrosis (CF), congenital hypothyroidism, phenylketonuria
(PKU), and around 22 other metabolic conditions that affect protein or fat metabolism can be diagnosed
through newborn screening tests.
© Coherent market Insights. All Rights Reserved